ReVision Optics Celebrates 1,000 Raindrop Near Vision Inlay Procedures Improving Near Vision for Individuals with Presbyopia

Recent survey of surgeons performing the Raindrop Inlay procedure finds 100% are likely to recommend Raindrop to another surgeon and a 94% satisfaction rate with patient outcomes

Company to participate in two upcoming ophthalmic conferences

LAKE FOREST, Calif.--()--ReVision Optics, Inc., a leader in implantable presbyopia-correcting corneal inlay technology, announces that 1,000 Raindrop® Near Vision Inlay procedures have been performed since the company’s commercial launch of the product in late August 2016. The Raindrop Near Vision Inlay is a novel corneal inlay for the surgical correction of presbyopia, which is a natural part of the aging process that decreases the ability of the eye to focus on near objects.

“It’s exciting to reach this milestone, moreover within eight months of our commercial launch. It’s even more exciting to improve the lives of those who previously struggled with everyday tasks like reading menus or seeing items on their smartphones,” said John Kilcoyne, ReVision Optics’ President and Chief Executive Officer. “More Americans are seeking out options to reduce the hassle of reading glasses by correcting presbyopia through outpatient procedures. The Raindrop Inlay is clearly a terrific option for those patients wanting to improve near vision and live life with a full range of vision.

“We are delighted with the reception our Raindrop Inlay has received from the ophthalmic community,” said Mr. Kilcoyne. “We now have 90+ surgeons performing the procedure and are processing requests for training daily. Results of our monthly survey for March 2017 of surgeons performing the procedure are typical of the responses we’ve received to date, with 100% indicating they would likely recommend the procedure to another surgeon and 94% saying they were satisfied with patient outcomes following the procedure.”

The Raindrop is a clear, biocompatible inlay that is placed in the non-dominant eye in a 10-minute outpatient procedure. The inlay is about the size of a pinhead and is less than half the thickness of a human hair. It mimics the properties of the natural cornea and changes the central curvature of the eye to improve near vision. ReVision Optics is commercializing the Raindrop Near Vision Inlay through a comprehensive marketing campaign and a commercial sales organization comprised of sales representatives and clinical outcomes specialists.

ReVision Optics also announces plans to participate in two upcoming ophthalmic conferences.

  • Mr. Kilcoyne will participate on a panel reviewing the scope of disruptive presbyopia technologies and their current market penetration at the Ophthalmic Innovation Summit (OIS) on May 4, 2017. The conference, which is expected to be attended by approximately 700 clinicians, industry representatives and investors, will be held at the Sheraton in downtown Los Angeles.
  • ReVision Optics will showcase the Raindrop Near Vision Inlay on the exhibition floor at the joint American Society of Cataract and Refractive Surgery (ASCRS) and American Society of Ophthalmic Administrators (ASOA) Symposium & Congress being held May 5-9, at the Los Angeles Convention Center. The ASCRS ASOA Symposium and Congress is expected to be the largest U.S. meeting integrating a scientific program dedicated to the needs of the anterior segment specialist with the leading practice management program for comprehensive ophthalmology and subspecialties. The ReVision Optics’ display will be at booth #2936.

About the Raindrop Near Vision Inlay

The Raindrop Near Vision Inlay is placed in the cornea of the non-dominant eye during a 10-minute procedure. The Raindrop is comprised of approximately 80% water and has a refractive index very similar to the cornea. It is transparent and therefore does not restrict the amount of light reaching the retina. The reshaping of the anterior curvature of the cornea improves near vision.

The Raindrop Near Vision Inlay has received approval by the U.S. Food and Drug Administration, authorization to affix the CE Mark for the European Union, license approval by the Ministry of Food and Drug Safety (South Korea), approval by the Therapeutic Goods Administration (Australia) and registration with the Medicines and Medical Safety Authority (New Zealand). Other country-specific registrations are pending.

About ReVision Optics

ReVision Optics, Inc. focuses on the development and commercialization of innovative optical solutions dedicated to presbyopic vision correction. The company’s Raindrop Near Vision Inlay offers a unique, patented refractive surgery solution. The Raindrop improves near vision that has been lost through the eye’s natural aging process called presbyopia. The Raindrop Near Vision Inlay provides a new surgical option for near-vision enhancement.

Contacts

COMPANY CONTACT
ReVision Optics, Inc.
John Kilcoyne
President & CEO
949-707-2740
jkilcoyne@revisionoptics.com
or
MEDIA CONTACT
LHA
Jody Cain
310-691-7100
jcain@lhai.com
@LHA_IR_PR

Contacts

COMPANY CONTACT
ReVision Optics, Inc.
John Kilcoyne
President & CEO
949-707-2740
jkilcoyne@revisionoptics.com
or
MEDIA CONTACT
LHA
Jody Cain
310-691-7100
jcain@lhai.com
@LHA_IR_PR